🇺🇸 FDA
Pipeline program

Medtronic Talent Stent-Graft-System

INSTEAD trial

Phase 3 other completed

Quick answer

Medtronic Talent Stent-Graft-System for Aortic Diseases is a Phase 3 program (other) at RHYTHM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
RHYTHM PHARMACEUTICALS, INC.
Indication
Aortic Diseases
Phase
Phase 3
Modality
other
Status
completed

Clinical trials